(Q45376971)

English

Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatment

scientific article published on 31 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatment (English)

1 reference

Europe PubMed Central

13 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

David Tabernero

object named as

D Tabernero

1

0 references

author name string

M J Sánchez

2

1 reference

Europe PubMed Central

13 December 2017

M Homs

3

1 reference

Europe PubMed Central

13 December 2017

F Rodríguez-Frías

4

1 reference

Europe PubMed Central

13 December 2017

R Jardí

5

1 reference

Europe PubMed Central

13 December 2017

M Schaper

6

1 reference

Europe PubMed Central

13 December 2017

R Esteban

7

1 reference

Europe PubMed Central

13 December 2017

M Buti

8

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

31 March 2010

1 reference

Europe PubMed Central

13 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

13 December 2017

32

1 reference

Europe PubMed Central

13 December 2017

1

1 reference

Europe PubMed Central

13 December 2017

97-104

1 reference

Europe PubMed Central

13 December 2017

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

The core promoter of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2010.04319.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2010.04319.X

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45376971&oldid=2076255767"